TG THERAPEUTICS INC (TGTX) Stock Fundamental Analysis

USA • Nasdaq • NASDAQ:TGTX • US88322Q1085

29.43 USD
-0.57 (-1.9%)
At close: Jan 30, 2026
29.55 USD
+0.12 (+0.41%)
After Hours: 1/30/2026, 8:21:07 PM
Fundamental Rating

5

Taking everything into account, TGTX scores 5 out of 10 in our fundamental rating. TGTX was compared to 525 industry peers in the Biotechnology industry. TGTX has an average financial health and profitability rating. TGTX is not priced too expensively while it is growing strongly. Keep and eye on this one!


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

  • TGTX had positive earnings in the past year.
  • In the past year TGTX has reported a negative cash flow from operations.
  • In multiple years TGTX reported negative net income over the last 5 years.
  • In the past 5 years TGTX always reported negative operating cash flow.
TGTX Yearly Net Income VS EBIT VS OCF VS FCFTGTX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100M -200M -300M

1.2 Ratios

  • TGTX has a Return On Assets of 43.65%. This is amongst the best in the industry. TGTX outperforms 99.24% of its industry peers.
  • TGTX has a better Return On Equity (73.69%) than 99.24% of its industry peers.
  • TGTX has a better Return On Invested Capital (9.35%) than 94.67% of its industry peers.
Industry RankSector Rank
ROA 43.65%
ROE 73.69%
ROIC 9.35%
ROA(3y)-35.91%
ROA(5y)-48.82%
ROE(3y)-121.2%
ROE(5y)-112.84%
ROIC(3y)N/A
ROIC(5y)N/A
TGTX Yearly ROA, ROE, ROICTGTX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200 -400 -600

1.3 Margins

  • The Profit Margin of TGTX (84.13%) is better than 98.67% of its industry peers.
  • With an excellent Operating Margin value of 19.32%, TGTX belongs to the best of the industry, outperforming 94.48% of the companies in the same industry.
  • TGTX's Gross Margin of 85.34% is amongst the best of the industry. TGTX outperforms 87.81% of its industry peers.
  • TGTX's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 19.32%
PM (TTM) 84.13%
GM 85.34%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.04%
GM growth 5YN/A
TGTX Yearly Profit, Operating, Gross MarginsTGTX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50K -100K -150K

4

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), TGTX is creating some value.
  • Compared to 1 year ago, TGTX has more shares outstanding
  • The number of shares outstanding for TGTX has been increased compared to 5 years ago.
  • The debt/assets ratio for TGTX is higher compared to a year ago.
TGTX Yearly Shares OutstandingTGTX Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
TGTX Yearly Total Debt VS Total AssetsTGTX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

  • An Altman-Z score of 6.70 indicates that TGTX is not in any danger for bankruptcy at the moment.
  • The Altman-Z score of TGTX (6.70) is better than 76.38% of its industry peers.
  • TGTX has a Debt/Equity ratio of 0.40. This is a healthy value indicating a solid balance between debt and equity.
  • Looking at the Debt to Equity ratio, with a value of 0.40, TGTX is doing worse than 69.52% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.4
Debt/FCF N/A
Altman-Z 6.7
ROIC/WACC1.05
WACC8.88%
TGTX Yearly LT Debt VS Equity VS FCFTGTX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M

2.3 Liquidity

  • TGTX has a Current Ratio of 3.82. This indicates that TGTX is financially healthy and has no problem in meeting its short term obligations.
  • TGTX's Current ratio of 3.82 is in line compared to the rest of the industry. TGTX outperforms 45.71% of its industry peers.
  • A Quick Ratio of 2.89 indicates that TGTX has no problem at all paying its short term obligations.
  • With a Quick ratio value of 2.89, TGTX is not doing good in the industry: 63.05% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 3.82
Quick Ratio 2.89
TGTX Yearly Current Assets VS Current LiabilitesTGTX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

8

3. Growth

3.1 Past

  • TGTX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 563.64%, which is quite impressive.
  • Looking at the last year, TGTX shows a very strong growth in Revenue. The Revenue has grown by 100.88%.
  • TGTX shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 364.59% yearly.
EPS 1Y (TTM)563.64%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%700%
Revenue 1Y (TTM)100.88%
Revenue growth 3Y266.39%
Revenue growth 5Y364.59%
Sales Q2Q%92.79%

3.2 Future

  • The Earnings Per Share is expected to grow by 92.99% on average over the next years. This is a very strong growth
  • TGTX is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 40.43% yearly.
EPS Next Y2068.02%
EPS Next 2Y252.71%
EPS Next 3Y161.58%
EPS Next 5Y92.99%
Revenue Next Year90.61%
Revenue Next 2Y67.58%
Revenue Next 3Y55.07%
Revenue Next 5Y40.43%

3.3 Evolution

  • The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
TGTX Yearly Revenue VS EstimatesTGTX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 500M 1B 1.5B 2B 2.5B
TGTX Yearly EPS VS EstimatesTGTX Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 0 2 -2 4

6

4. Valuation

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 57.71, the valuation of TGTX can be described as expensive.
  • Compared to the rest of the industry, the Price/Earnings ratio of TGTX indicates a rather cheap valuation: TGTX is cheaper than 91.05% of the companies listed in the same industry.
  • TGTX's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 28.30.
  • TGTX is valuated correctly with a Price/Forward Earnings ratio of 16.90.
  • Based on the Price/Forward Earnings ratio, TGTX is valued cheaper than 94.86% of the companies in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 25.57. TGTX is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 57.71
Fwd PE 16.9
TGTX Price Earnings VS Forward Price EarningsTGTX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

  • TGTX's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. TGTX is cheaper than 91.24% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 46.87
TGTX Per share dataTGTX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3

4.3 Compensation for Growth

  • TGTX's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • TGTX has a very decent profitability rating, which may justify a higher PE ratio.
  • A more expensive valuation may be justified as TGTX's earnings are expected to grow with 161.58% in the coming years.
PEG (NY)0.03
PEG (5Y)N/A
EPS Next 2Y252.71%
EPS Next 3Y161.58%

0

5. Dividend

5.1 Amount

  • TGTX does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

TG THERAPEUTICS INC / TGTX FAQ

What is the fundamental rating for TGTX stock?

ChartMill assigns a fundamental rating of 5 / 10 to TGTX.


What is the valuation status for TGTX stock?

ChartMill assigns a valuation rating of 6 / 10 to TG THERAPEUTICS INC (TGTX). This can be considered as Fairly Valued.


Can you provide the profitability details for TG THERAPEUTICS INC?

TG THERAPEUTICS INC (TGTX) has a profitability rating of 6 / 10.


Can you provide the financial health for TGTX stock?

The financial health rating of TG THERAPEUTICS INC (TGTX) is 4 / 10.


What is the earnings growth outlook for TG THERAPEUTICS INC?

The Earnings per Share (EPS) of TG THERAPEUTICS INC (TGTX) is expected to grow by 2068.02% in the next year.